X

Vous n'êtes pas connecté

Rubriques :

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 02/Sep 11:21

Aptamer signs therapeutic development agreement with Invizius

Aptamer Group plc, the developer of next-generation synthetic binders for the life sciences industry, is pleased to announce that it has signed a new therapeutic development agreement with Invizius, a clinical-stage biotechnology company focused on second-generation complement system therapies for inflammatory, fibrotic, and autoimmune diseases.

Articles similaires

Sorry! Image not available at this time

Dianthus Therapeutics to Host Conference Call and Webcast to Discuss Results from Phase 2 MaGic Trial of Claseprubart (DNTH103) in Generalized Myasthenia Gravis

mangaloremirror.com - 07/Sep 22:55

NEW YORK and WALTHAM, Mass., Sept. 07, 2025 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company...

Sorry! Image not available at this time

Dianthus Therapeutics to Host Conference Call and Webcast to Discuss Results from Phase 2 MaGic Trial of Claseprubart (DNTH103) in Generalized Myasthenia Gravis

mangaloremirror.com - 07/Sep 22:55

NEW YORK and WALTHAM, Mass., Sept. 07, 2025 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company...

Sorry! Image not available at this time

RESTEM to Host R&D Day Highlighting its Next-Generation Immunomodulatory Treatment for Autoimmune and Inflammatory Diseases

healthtechzone.com - 11/Sep 16:00

Sorry! Image not available at this time

Ocugen and Kwangdong Pharma complete license agreement of OCU400 modifier gene therapy for retinitis pigmentosa in Korea

pharmabiz.com - 16/Sep 06:06

Ocugen, Inc., a pioneering biotechnology leader in gene therapies for blindness diseases, executed a licensing agreement with Kwangdong...

Sorry! Image not available at this time

Biocytogen Announces ADC Innovator Tubulis Has Signed Global Exclusive License Agreement for Single Antibody

financialpost.com - 16/Sep 00:02

BEIJING — Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company that drives the research and...

Sorry! Image not available at this time

Biocytogen Announces ADC Innovator Tubulis Has Signed Global Exclusive License Agreement for Single Antibody

wn.com - 16/Sep 04:43

BEIJING--(BUSINESS WIRE)--#ADCTherapeutics--Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, HKEX: 02315), a global biotechnology company...

Sorry! Image not available at this time

Adani Power signs 25-year agreement with BSPGCL to supply 2.4GW of power

power-technology.com - 15/Sep 08:54

India’s Adani Power Limited (APL) has signed a 25-year power supply agreement (PSA) with Bihar State Power Generation Company Limited (BSPGCL) to...

Sorry! Image not available at this time

TUI Group Signs Strategic Alliance Agreement with Oman

ittn.ie - 09:20

TUI Group and The Sultanate of Oman’s Tourism Development Company OMRAN Group have signed a strategic agreement, outlining a long-term strategic...

Sorry! Image not available at this time

Saisei Ventures Appoints James Feliciano as Venture Partner

wn.com - 15/Sep 17:35

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Saisei Ventures, a leading investment firm focused on advancing Japanese biotechnology and therapeutic innovations,...

Sorry! Image not available at this time

IDB signs EGP 1.13bn credit facility agreement with Raya

dailynewsegypt.com - 07/Sep 18:54

The Industrial Development Bank (IDB) has signed a credit facility agreement worth EGP 1.13bn with Raya Information Technology, a subsidiary of Raya...

Les derniers communiqués